| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.074 | 0.01 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.07 | 0.01 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.01 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.17 | 0.02 |